JP2015521192A5 - - Google Patents

Download PDF

Info

Publication number
JP2015521192A5
JP2015521192A5 JP2015514375A JP2015514375A JP2015521192A5 JP 2015521192 A5 JP2015521192 A5 JP 2015521192A5 JP 2015514375 A JP2015514375 A JP 2015514375A JP 2015514375 A JP2015514375 A JP 2015514375A JP 2015521192 A5 JP2015521192 A5 JP 2015521192A5
Authority
JP
Japan
Prior art keywords
group
independently
ring
phenyl
pyridine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015514375A
Other languages
English (en)
Japanese (ja)
Other versions
JP6209210B2 (ja
JP2015521192A (ja
Filing date
Publication date
Priority claimed from EP20120170227 external-priority patent/EP2669286A1/en
Application filed filed Critical
Publication of JP2015521192A publication Critical patent/JP2015521192A/ja
Publication of JP2015521192A5 publication Critical patent/JP2015521192A5/ja
Application granted granted Critical
Publication of JP6209210B2 publication Critical patent/JP6209210B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015514375A 2012-05-31 2013-05-10 神経変性疾患の処置のために有用なスピロテトラヒドロ−ベンゾチオフェン誘導体 Expired - Fee Related JP6209210B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP20120170227 EP2669286A1 (en) 2012-05-31 2012-05-31 Spiro tetrahydro-benzothiophen derivatives useful for the treatment of neurodegenerative diseases
EP12170227.8 2012-05-31
US201261655078P 2012-06-04 2012-06-04
US61/655,078 2012-06-04
PCT/EP2013/001389 WO2013178322A1 (en) 2012-05-31 2013-05-10 Spiro tetrahydro - benzothiophen derivatives useful for the treatment neurodegenerative diseases

Publications (3)

Publication Number Publication Date
JP2015521192A JP2015521192A (ja) 2015-07-27
JP2015521192A5 true JP2015521192A5 (enExample) 2017-09-14
JP6209210B2 JP6209210B2 (ja) 2017-10-04

Family

ID=46210136

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015514375A Expired - Fee Related JP6209210B2 (ja) 2012-05-31 2013-05-10 神経変性疾患の処置のために有用なスピロテトラヒドロ−ベンゾチオフェン誘導体

Country Status (9)

Country Link
US (1) US9233982B2 (enExample)
EP (2) EP2669286A1 (enExample)
JP (1) JP6209210B2 (enExample)
CN (1) CN104364258B (enExample)
AU (1) AU2013269996B2 (enExample)
CA (1) CA2875132C (enExample)
ES (1) ES2581540T3 (enExample)
IL (1) IL235955B (enExample)
WO (1) WO2013178322A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013181202A2 (en) 2012-05-30 2013-12-05 Astellas Pharma Inc. Chromane compounds
US9580396B2 (en) 2012-12-21 2017-02-28 Merck Sharp & Dohme Corp. C6-spiro iminothiadiazine dioxides as BACE inhibitors, compositions, and their use
US9725468B2 (en) 2013-09-13 2017-08-08 Merck Sharp & Dohme Corp. C5-spiro iminothiazine dioxides as BACE inhibitors, compositions, and their use
US10238743B2 (en) 2014-10-03 2019-03-26 Merck Sharp & Dohme Corp. C5-C6-fused tricyclic iminothiadiazine dioxide compounds as BACE inhibitors, compositions, and their use
ES2887087T3 (es) 2015-05-07 2021-12-21 Bristol Myers Squibb Co Sulfonas tricíclicas como moduladores ROR gamma
KR20190057388A (ko) 2016-10-10 2019-05-28 브리스톨-마이어스 스큅 컴퍼니 Ror 감마 조정제로서의 트리시클릭 술폰
BR112019025212A2 (pt) * 2017-06-14 2020-06-16 Nippon Soda Co., Ltd. Composto, formulações para controlar organismos nocivos, para controlar ectoparasitas, para controlar pragas de insetos thysanoptera, e, formulação inseticida ou acaricida

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7763609B2 (en) * 2003-12-15 2010-07-27 Schering Corporation Heterocyclic aspartyl protease inhibitors
CN101489984B (zh) * 2006-07-18 2013-04-03 安斯泰来制药株式会社 氨基茚满衍生物或其盐
WO2008133273A1 (ja) * 2007-04-24 2008-11-06 Shionogi & Co., Ltd. アルツハイマー症治療用医薬組成物
WO2010013794A1 (en) 2008-07-28 2010-02-04 Eisai R&D Management Co., Ltd. Spiroaminodihydrothiazine derivatives
JP5444240B2 (ja) * 2008-07-28 2014-03-19 エーザイ・アール・アンド・ディー・マネジメント株式会社 スピロアミノジヒドロチアジン誘導体
PT2406240E (pt) * 2009-03-13 2016-02-24 Boehringer Ingelheim Int Inibidores de beta-secretase
CN102812005B (zh) * 2010-02-24 2014-12-10 生命医药公司 β-分泌酶抑制剂
US20120065195A1 (en) * 2010-03-31 2012-03-15 Clark Christopher T Compounds for treating neurodegenerative diseases

Similar Documents

Publication Publication Date Title
JP2015521192A5 (enExample)
JP2013531029A5 (enExample)
JP2013523802A5 (enExample)
IL264541A (en) History of sulfamolepyrolamide and their use as drugs for the treatment of jaundice b
JP2018528946A5 (enExample)
EA201391558A1 (ru) Тетрагидропиразоло[1,5-а]пиримидины как противотуберкулезные соединения
PE20141033A1 (es) COMPUESTOS Y COMPOSICIONES COMO INHIBIDORES DE LA QUINASA c-KIT
RU2014140735A (ru) ПРОИЗВОДНЫЕ ПИРАЗОЛО[1, 5-a]ПИРИМИДИНА, КОМПОЗИЦИИ, СОДЕРЖАЩИЕ УКАЗАННЫЕ СОЕДИНЕНИЯ, И СПОСОБЫ ИХ ПРИМЕНЕНИЯ
JP2013147496A5 (ja) 有機金属錯体
JP2016506958A5 (enExample)
JP2013507434A5 (enExample)
JP2016006118A5 (enExample)
GEP201706735B (en) Kinase inhibitors
JP2013010749A5 (ja) カルバゾール化合物
JP2012140432A5 (enExample)
JP2015514808A5 (enExample)
JP2012512863A5 (enExample)
JP2016531858A5 (enExample)
ME02838B (me) 3,4-dihidroizokinolin-2(1h)-ilni spojevi
AR080802A1 (es) Compuestos de complejos de fe (iii) para el tratamiento y la profilaxis de los sintomas de deficiencia de hierro y anemias por deficiencia de hierro
JP2016503797A5 (enExample)
MX375556B (es) Compuestos de benzoxaborol tricíclicos y usos de los mismos.
MX2016006685A (es) Compuestos heterociclicos de n-acilimino.
JP2019529419A5 (enExample)
AR071592A1 (es) Fenoxibenzamidas sustituidas